Stock listing
Novaccess Global Inc.
Selected listing: XSNX · OTC · USD · US
Novaccess Global Inc. (OTC:XSNX), Health Technology. Latest release May 21, 2024: NovAccess Global Files Patent with Cedars-Sinai to Advance its Brain Cancer…
- Ticker
- OTC:XSNX
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
About Novaccess Global Inc.
Novaccess Global Inc. is a public company traded under the ticker XSNX in the American market. Investors can find relevant information and updates about Novaccess Global Inc. on its dedicated public company page.
Latest news from Novaccess Global Inc.
NovAccess Global Files Patent with Cedars-Sinai to Advance its Brain Cancer Fighting Vaccine Platform
May 20, 2024
NovAccess Global Advisory on Annual Meeting of Shareholders
May 6, 2024
NovAccess Global Announces New License to Advance its Immunotherapy Platform
April 29, 2024
NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders
February 29, 2024
NovAccess Global Announces $10.7 Million Financing
January 1, 2024
Research Novaccess Global Inc.
Novaccess Global Inc. company profile
View the public company page for Novaccess Global Inc. on 6ix.
Novaccess Global Inc. news
Read company news and market updates connected to Novaccess Global Inc..
Novaccess Global Inc. investor events
Find investor webinars, events, and replay context for Novaccess Global Inc..